Form EFFECT NERVGEN PHARMA CORP.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 26, 2026 4:00 P.M. |
| Form: | F-10 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NervGen Pharma Corp (NGEN) PT Lowered to $15 at H.C. Wainwright
- Leerink Starts NervGen Pharma Corp (NGEN) at Outperform
- New Platform AgencyRank Helps UK Businesses Find the Right Marketing Agency
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share